Cargando…

Headache symptoms of the PREEMPT population

Detalles Bibliográficos
Autores principales:	Dodick, DW, DeGryse, RE, Turkel, CC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620370/ http://dx.doi.org/10.1186/1129-2377-14-S1-P99

Ejemplares similares

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT
por: Aurora, SK, et al.
Publicado: (2013)

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
por: Diener, HC, et al.
Publicado: (2013)

The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
por: Silberstein, S, et al.
Publicado: (2013)

OnabotulinumtoxinA for chronic migraine treatment: 75% responder analysis from double-blind, randomized, placebo-controlled phase of PREEMPT
por: Dodick, D, et al.
Publicado: (2013)

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program
por: Aurora, SK, et al.
Publicado: (2014)

Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
por: Silberstein, Stephen D, et al.
Publicado: (2015)

The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
por: Matharu, Manjit, et al.
Publicado: (2017)

Migraine headache is present in the aura phase – a prospective study
por: Hansen, JM, et al.
Publicado: (2013)

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program
por: Lipton, Richard B, et al.
Publicado: (2016)

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
por: Silberstein, Stephen D., et al.
Publicado: (2020)

Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
por: Diener, H-C, et al.
Publicado: (2014)

Major life events, stress appraisal, and migraine: results of the American Migraine Prevalence and Prevention (AMPP) study
por: Manack, AN, et al.
Publicado: (2013)

Headache as a symptom of Multiple Sclerosis
por: Kalamatas, T, et al.
Publicado: (2013)

Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes
por: Blumenfeld, Andrew M., et al.
Publicado: (2017)

Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine
por: Rendas-Baum, Regina, et al.
Publicado: (2014)

Clinical profile of probable cluster headache without ipsilateral autonomous symptoms
por: Imai, N
Publicado: (2013)

P056. Clinical case: headache as a symptom of another disease detector
por: Tripodi, Fortunata
Publicado: (2015)

Neurocognitive function declines are reversible following migraine headache in college students
por: Moore, MT, et al.
Publicado: (2013)

Pericranial muscle tenderness in a population based sample of chronic tension-type headache. The Akershus study of chronic headache
por: Aaseth, K, et al.
Publicado: (2013)

Does a Pandemic Preempt Participatory Medicine?
por: Millenson, Michael Louis
Publicado: (2020)

Preempting Bronchopulmonary Dysplasia: Time to Focus on the Placenta?
por: Thébaud, Bernard
Publicado: (2021)

Cognitive, emotional and somatic symptoms among patients with chronic posttraumatic headache. A controlled study
por: Kjeldgaard, D, et al.
Publicado: (2013)

Coexistence of “headache attributed to airplane travel” and “mountain descending headache”
por: Mainardi, F, et al.
Publicado: (2013)

Headaches in the elderly, in an out-patient population over 60 years of age
por: Venturelli, E, et al.
Publicado: (2013)

Headache disorders in a tertiary care headache outpatient clinic in Austria
por: Fischer, M, et al.
Publicado: (2013)

P023. Reasons for headache investigation and findings in an experimental headache center
por: Panconesi, Alessandro, et al.
Publicado: (2015)

Side locked headaches
por: Momoh-Ojewuyi, A, et al.
Publicado: (2013)

Occipital locked headache
por: Whitehouse, A, et al.
Publicado: (2013)

Review of headache in pregnancy
por: Jalilian, Nasrin, et al.
Publicado: (2012)

P040. Primary Valsalva maneuver headache without primary cough headache
por: Ferrante, Enrico
Publicado: (2015)

Can induced headache be used in the differential diagnosis of primary headaches as a diagnostic tool?
por: Ýdiman, Fethi, et al.
Publicado: (2013)

EUROLIGHT project: impact of primary headache disorders from a population-based study conducted in Pavia
por: Allena, M, et al.
Publicado: (2013)

Self-reported efficacy of complementary and alternative medicine in chronic headache subjects in the general population
por: Kristoffersen, ES, et al.
Publicado: (2013)

36. All headaches are not GCA
por: Jain, Nibha, et al.
Publicado: (2019)

Prevalence of chronic idiopathic musculoskeletal pain and headache in adolescence: a population based Norwegian study
por: Hoftun, Gry B, et al.
Publicado: (2012)

Accessibility of headache centers for patients suffering for cluster headache in Italy: too far from the patients’ needs
por: Rossi, P, et al.
Publicado: (2013)

Headache and wine. Are all wines the same?
por: Diaz-Insa, S, et al.
Publicado: (2013)

P069. Osmophobia in children with headache
por: Bosetti, Francesca M, et al.
Publicado: (2015)

P071. Headache self-administered questionnaire in the waiting room, a useful and easy tool for headache centres
por: Catarci, Teresa
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v3cifrsr4nfku7rpt1vc2lv343